PCM
Polaris Capital Management’s United Therapeutics UTHR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.7M | Sell |
127,650
-9,400
| -7% | -$2.7M | 2.44% | 10 |
|
|
2025
Q1 | $42.2M | Buy |
137,050
+5,200
| +4% | +$1.6M | 2.42% | 9 |
|
|
2024
Q4 | $46.5M | Sell |
131,850
-10,100
| -7% | -$3.56M | 2.24% | 9 |
|
|
2024
Q3 | $50.9M | Sell |
141,950
-6,600
| -4% | -$2.37M | 2.51% | 8 |
|
|
2024
Q2 | $47.3M | Buy |
148,550
+18,600
| +14% | +$5.93M | 2.54% | 6 |
|
|
2024
Q1 | $29.9M | Sell |
129,950
-12,600
| -9% | -$2.89M | 1.49% | 35 |
|
|
2023
Q4 | $31.3M | Buy |
142,550
+8,000
| +6% | +$1.76M | 1.51% | 34 |
|
|
2023
Q3 | $30.4M | Sell |
134,550
-58,600
| -30% | -$13.2M | 1.64% | 32 |
|
|
2023
Q2 | $42.6M | Sell |
193,150
-1,000
| -0.5% | -$221K | 1.6% | 32 |
|
|
2023
Q1 | $43.5M | Sell |
194,150
-127,250
| -40% | -$28.5M | 1.62% | 33 |
|
|
2022
Q4 | $89.4M | Sell |
321,400
-20,500
| -6% | -$5.7M | 3.11% | 6 |
|
|
2022
Q3 | $71.6M | Sell |
341,900
-9,300
| -3% | -$1.95M | 2.81% | 6 |
|
|
2022
Q2 | $82.8M | Sell |
351,200
-3,000
| -0.8% | -$707K | 2.96% | 6 |
|
|
2022
Q1 | $63.5M | Sell |
354,200
-20,600
| -5% | -$3.7M | 2.02% | 12 |
|
|
2021
Q4 | $81M | Sell |
374,800
-6,100
| -2% | -$1.32M | 2.61% | 7 |
|
|
2021
Q3 | $70.3M | Sell |
380,900
-1,200
| -0.3% | -$221K | 2.24% | 14 |
|
|
2021
Q2 | $68.6M | Buy |
382,100
+1,600
| +0.4% | +$287K | 2.21% | 12 |
|
|
2021
Q1 | $72.2M | Buy |
+380,500
| New | +$72.2M | 2.37% | 10 |
|